These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36799143)

  • 1. Enablers and barriers to COVID-19 vaccine uptake in an urban slum in Lagos, Nigeria: informing vaccine engagement strategies for the marginalized.
    Ozoh OB; Akinkugbe AO; Olukoya MA; Adetifa IMO
    Int Health; 2023 Sep; 15(5):557-565. PubMed ID: 36799143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    Kalam MA; Davis TP; Shano S; Uddin MN; Islam MA; Kanwagi R; Islam A; Hassan MM; Larson HJ
    PLoS One; 2021; 16(8):e0256496. PubMed ID: 34424913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the beliefs and experiences with regard to COVID-19 vaccine hesitancy and acceptance in a slum of Karachi, Pakistan.
    Qasim R; Shah H; Sultan A; Yaqoob M; Haroon R; Mistry SK; Bestman A; Yousafzai MT; Yadav UN
    Health Promot Int; 2022 Dec; 37(6):. PubMed ID: 36300701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological determinants of COVID-19 vaccine acceptance among urban slum dwellers of Bangladesh.
    Patwary MM; Bardhan M; Al Imran S; Hasan M; Imam Tuhi F; Rahim SJ; Newaz MN; Hasan M; Haque MZ; Disha AS; Hossain MR; Rodriguez-Morales AJ; Saeed F; Nazari SK; Shoib S
    Front Public Health; 2022; 10():958445. PubMed ID: 36187665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing vaccine hesitancy and resistance for COVID-19 vaccines.
    Peters MDJ
    Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural Determinants of COVID-19-Vaccine Acceptance in Rural Areas of Six Lower- and Middle-Income Countries.
    Davis TP; Yimam AK; Kalam MA; Tolossa AD; Kanwagi R; Bauler S; Kulathungam L; Larson H
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Public's Attitudes Toward COVID-19 Vaccines in Nottinghamshire, United Kingdom: Qualitative Social Media Analysis.
    Jones LF; Bonfield S; Farrell J; Weston D
    J Med Internet Res; 2023 Mar; 25():e38404. PubMed ID: 36812390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
    Wonodi C; Obi-Jeff C; Adewumi F; Keluo-Udeke SC; Gur-Arie R; Krubiner C; Jaffe EF; Bamiduro T; Karron R; Faden R
    Vaccine; 2022 Mar; 40(13):2114-2121. PubMed ID: 35153088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholders' hopes and concerns about the COVID-19 vaccines in Southeastern Nigeria: a qualitative study.
    Chukwuocha UM; Emerole CO; Iwuoha GN; Dozie UW; Njoku PU; Akanazu CO; Eteike PO; Hemingway C
    BMC Public Health; 2022 Feb; 22(1):330. PubMed ID: 35172789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care seeking for under-five children and vaccine perceptions during the first two waves of the COVID-19 pandemic in Lagos State, Nigeria: a qualitative exploratory study.
    Bakare AA; Olojede OE; King C; Graham H; Uchendu O; Colbourn T; Falade AG; Alvesson HM; ;
    BMJ Open; 2023 Mar; 13(3):e069294. PubMed ID: 36882237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination acceptance in underserved urban areas of Islamabad and Rawalpindi: results from a cross-sectional survey.
    Kazmi T; Abdullah M; Khan AA; Safdar RM; Afzal S; Khan A
    BMC Public Health; 2022 Dec; 22(1):2299. PubMed ID: 36482435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria.
    Osibogun AO; Shuaib FM; Adeyeye CM; Onajole AT; Ejembi CL; Banwat ME; Wright KO; Mohammed A; Adeleye OA; Yahya SJ; Ifeadike CO; Elemuwa UU; Bassey BE; Oluwole EO; Erinoso OA
    Niger Postgrad Med J; 2023; 30(1):18-24. PubMed ID: 36814159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community voices around COVID-19 vaccine in Chennai, India: A qualitative exploration during early phase of vaccine rollout.
    Kumar MS; Madhumathi J; Gayathri K; A Rozario AG; Vijayaprabha R; Balusamy M; Sonekar H; Panda S
    Indian J Med Res; 2022; 155(5&6):451-460. PubMed ID: 35975352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
    Sato R
    Vaccine; 2023 Apr; 41(17):2749-2753. PubMed ID: 36959055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to COVID-19 vaccination of migrant populations: A qualitative interview study of immunisation providers in Victoria, Australia.
    Tuckerman J; Kaufman J; Overmars I; Holland P; Danchin M
    Vaccine; 2023 Aug; 41(35):5085-5089. PubMed ID: 37460355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine hesitancy in Africa: a scoping review.
    Ackah BBB; Woo M; Stallwood L; Fazal ZA; Okpani A; Ukah UV; Adu PA
    Glob Health Res Policy; 2022 Jul; 7(1):21. PubMed ID: 35850783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and uptake of COVID-19 vaccines amongst undergraduate students in a tertiary institution in Lagos State.
    Akinsunmade OM; Ogunyemi AO; Isikekpei BC; Maduafokwa BA; Otokpa E; Okerinde SS
    Niger Postgrad Med J; 2023; 30(2):104-109. PubMed ID: 37148111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine hesitancy among healthcare workers and its socio-demographic determinants in Abia State, Southeastern Nigeria: a cross-sectional study.
    Amuzie CI; Odini F; Kalu KU; Izuka M; Nwamoh U; Emma-Ukaegbu U; Onyike G
    Pan Afr Med J; 2021; 40():10. PubMed ID: 34650660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enablers and barriers to vaccine uptake and handwashing practices to prevent and control COVID-19 in Kenya, Uganda, and Tanzania: a systematic review.
    Muchangi JM; Mturi J; Mukasa H; Kithuki K; Kosgei SJ; Kanyangi LM; Moraro R; Nankanja M
    Front Public Health; 2024; 12():1352787. PubMed ID: 38601496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.